Review Special Issues

Gene-environment interactions in considering physical activity for the prevention of dementia

  • Received: 29 June 2015 Accepted: 01 September 2015 Published: 08 September 2015
  • Alzheimer's disease (AD), the most common neurodegenerative disease worldwide, ranks as one of the most feared diseases in the world. Similarly, recent studies suggest that AD may be the third leading cause of death in the United States, behind heart disease and cancer. In the absence of a cure or effective treatment, strategies to prevent or delay the onset and progression of the disease are desperately needed. Decades of research have identified key risk and protective factors including genetic polymorphism in the APOE gene, age and lifestyle factors. Physical activity (PA) is emerging as an attractive primary prevention strategy. This review will summarise the latest findings supporting the role of physical activity in the prevention of AD, including possible mechanisms and the influence of genetics on disease prevention. Given that AD and other dementias are recognised as a world health priority, public health strategies are needed to incorporate promoting the health benefits of physical activity across the lifespan.

    Citation: Kristyn Alissa Bates. Gene-environment interactions in considering physical activity for the prevention of dementia[J]. AIMS Molecular Science, 2015, 2(3): 359-381. doi: 10.3934/molsci.2015.3.359

    Related Papers:

    [1] Ma Jun, Han Xinyu, Xu Qian, Chen Shiyou, Zhao Wenbo, Li Xiaoke . Reliability-based EDM process parameter optimization using kriging model and sequential sampling. Mathematical Biosciences and Engineering, 2019, 16(6): 7421-7432. doi: 10.3934/mbe.2019371
    [2] Charles Wiseman, M.D. . Questions from the fourth son: A clinician reflects on immunomonitoring, surrogate markers and systems biology. Mathematical Biosciences and Engineering, 2011, 8(2): 279-287. doi: 10.3934/mbe.2011.8.279
    [3] Dongning Chen, Jianchang Liu, Chengyu Yao, Ziwei Zhang, Xinwei Du . Multi-strategy improved salp swarm algorithm and its application in reliability optimization. Mathematical Biosciences and Engineering, 2022, 19(5): 5269-5292. doi: 10.3934/mbe.2022247
    [4] Zulqurnain Sabir, Hafiz Abdul Wahab, Juan L.G. Guirao . A novel design of Gudermannian function as a neural network for the singular nonlinear delayed, prediction and pantograph differential models. Mathematical Biosciences and Engineering, 2022, 19(1): 663-687. doi: 10.3934/mbe.2022030
    [5] Zulqurnain Sabir, Muhammad Asif Zahoor Raja, Aldawoud Kamal, Juan L.G. Guirao, Dac-Nhuong Le, Tareq Saeed, Mohamad Salama . Neuro-Swarm heuristic using interior-point algorithm to solve a third kind of multi-singular nonlinear system. Mathematical Biosciences and Engineering, 2021, 18(5): 5285-5308. doi: 10.3934/mbe.2021268
    [6] Konstantin Weise, Erik Müller, Lucas Poßner, Thomas R. Knösche . Comparison of the performance and reliability between improved sampling strategies for polynomial chaos expansion. Mathematical Biosciences and Engineering, 2022, 19(8): 7425-7480. doi: 10.3934/mbe.2022351
    [7] Xuewei Wang, Xiaohu Zhao, Fei Li, Qiang Lin, Zhenghui Hu . Sample entropy and surrogate data analysis for Alzheimer’s disease. Mathematical Biosciences and Engineering, 2019, 16(6): 6892-6906. doi: 10.3934/mbe.2019345
    [8] Zulqurnain Sabir, Muhammad Asif Zahoor Raja, Abeer S. Alnahdi, Mdi Begum Jeelani, M. A. Abdelkawy . Numerical investigations of the nonlinear smoke model using the Gudermannian neural networks. Mathematical Biosciences and Engineering, 2022, 19(1): 351-370. doi: 10.3934/mbe.2022018
    [9] Nawaz Ali Zardari, Razali Ngah, Omar Hayat, Ali Hassan Sodhro . Adaptive mobility-aware and reliable routing protocols for healthcare vehicular network. Mathematical Biosciences and Engineering, 2022, 19(7): 7156-7177. doi: 10.3934/mbe.2022338
    [10] Xiaoye Zhao, Yinlan Gong, Lihua Xu, Ling Xia, Jucheng Zhang, Dingchang Zheng, Zongbi Yao, Xinjie Zhang, Haicheng Wei, Jun Jiang, Haipeng Liu, Jiandong Mao . Entropy-based reliable non-invasive detection of coronary microvascular dysfunction using machine learning algorithm. Mathematical Biosciences and Engineering, 2023, 20(7): 13061-13085. doi: 10.3934/mbe.2023582
  • Alzheimer's disease (AD), the most common neurodegenerative disease worldwide, ranks as one of the most feared diseases in the world. Similarly, recent studies suggest that AD may be the third leading cause of death in the United States, behind heart disease and cancer. In the absence of a cure or effective treatment, strategies to prevent or delay the onset and progression of the disease are desperately needed. Decades of research have identified key risk and protective factors including genetic polymorphism in the APOE gene, age and lifestyle factors. Physical activity (PA) is emerging as an attractive primary prevention strategy. This review will summarise the latest findings supporting the role of physical activity in the prevention of AD, including possible mechanisms and the influence of genetics on disease prevention. Given that AD and other dementias are recognised as a world health priority, public health strategies are needed to incorporate promoting the health benefits of physical activity across the lifespan.


    $ \beta $: Target reliability; $ X $: Random variable; $ {\mu }_{X} $: The mean of$ X $; $ d $: Deterministic design variable; GMSE: Generalized mean square cross-validation error; SORA: Sequential optimization and reliability assessment; SVM: Support vector machine; DDV: Deterministic design variable; SVR: Support vector regression; MCC: Multiple correlation coefficient; RBDO: Reliability-based design optimization; MCS: Monte Carlo simulation; DRM: Dimensionality reduction methods; RBF: Radial basis functions; RAAE: Relative average absolute error; LHD: Latin hypercube design; RMSE: Root mean squared error; FFD: Full factorial design; RRMSE: Relative root mean squared error; KKT: Karush Kuhn Tucker; RMAE: Relative maximum absolute error; VF: Variable fidelityFORM: First-order reliability methods; LF: Low fidelity; CBS: Constraint boundary sampling; HF: High fidelity; EGRA: Efficient global reliability analysis; LAS: Local adaptive sampling; EGO: Efficient global optimization; MPP: Most possible point; PRS: Polynomial response surfaces; RIA: Reliability index approach; EFF: Expected feasibility function; PMA: Performance measure approach

    To improve the production efficiency and reduce manufacturing cost, design optimization of structure or system has become an inevitable trend in modern product. Due to the various uncertainty in engineering, the traditional deterministic design optimization method cannot ensure the practical application effect. On the other hand, in methods based on safety factor, the selection of safety factor depends on the manufacturing capacity and quality control means of the enterprise, which does not provide a quantitative measure of the safety margin and is not quantitatively linked to the influence of different design variables [1,2]. Furthermore, with emergence of new processes, new methods and new production conditions, the safety factor is difficult to determine, which also makes it difficult to cope with the complex environment of design, manufacture and use. RBDO is a natural extension of deterministic optimization method, where various uncertainty such as material properties, load conditions, manufactures, assembly and surrounding environment are considered. By considering the random distribution of various factors that affect the output response (stress, strain, vibration, fatigue, etc.) in the design optimization stage, RBDO can adapt to the complex environment in practical engineering, so that the production efficiency and manufacturing cost can be balanced.

    In RBDO, the optimal solution that meets the minimum reliability level is searched. The RBDO model is defined as follows [3,4]:

    $ \text{find}:\mathrm{d}, {\mu }_{X} \\ \mathit{min}:f(d, {\mu }_{X}) \\ \text{s.t.:}P\left({g}_{i}\right(d, X)\le 0)-{\mathit \Phi } (-{\beta }_{i}^{t})\le 0, \hspace{0.33em}i = \mathrm{1, 2}, \cdots , N \\ \hspace{1em}\hspace{1em}{d}^{L}\le d\le {d}^{U}, {\mu }_{X}^{L}\le {\mu }_{X}\le {\mu }_{X}^{U} $ (1)

    In Eq. (1), $ d $ is the deterministic design variable with the upper bound $ {d}^{U} $ and lower bound $ {d}^{L} $; $ X $ is the random variable, whose mean is $ {\mu }_{X} $ with the upper bound $ {\mu }_{X}^{U} $ and lower bound $ {\mu }_{X}^{L} $; $ f(d, {\mu }_{X}) $ is the objective function; $ {g}_{i}(d, X) $ is the performance function, whose value less than 0 is regarded as a failure event; $ {\beta }_{i}^{t} $ is the target reliability; $ {\mathit \Phi } (-{\beta }_{i}^{t}) $ is the maximum allowable failure probability.

    Because of the uncertainty of random variable $ X $, the output response of the performance function at any point is also uncertain, so the failure probability $ P\left({g}_{i}\right(d, X)\le 0) $ can be defined as follows:

    $ {F}_{G}\left(g\right) = P\left({g}_{i}\left(d, X\right)\le 0\right) = {\int }_{{g}_{i}\left(X\right)\le 0}\cdots \int {f}_{X}\left(X\right)dX $ (2)

    In Eq. (2), $ {f}_{X}\left(X\right) $ is the joint probability density function of random variable $ X $. As can be seen, Eq. (2) is a multi-dimensional integral problem, which is difficult to solve in engineering. Therefore, a variety of reliability analysis methods are developed to avoid solving the multi-dimensional integral problem directly [5,6,7].

    Reliability analysis is an important part of RBDO, which is used to evaluate the reliability level of current design. Commonly used reliability analysis methods can be divided into traditional analytical methods [8,9] and numerical simulation methods [10,11]. The traditional analytic method calculates the failure probability by expanding the performance function at a specific point in a Taylor series or approximating the probability density function in Eq. (2).

    Traditional analytical methods include methods based on probability density function approximation [12] and methods based on most probable (failure) point, MPP [13]. The former evaluates the probability density of performance function by assuming the output distribution type. The latter calculates the failure probability by expanding the performance function at a specific point in a Taylor series. MPP based methods include first-order reliability methods (FORM) [14,15], second-order reliability methods (SORM) [16,17,18] and MPP point-based dimensionality reduction methods (DRM) [19]. The traditional analytical methods are efficient, but for complex performance function, the calculation accuracy is poor.

    Different from traditional analytical methods, the numerical simulation methods evaluate the responses of a large number of samples, then the failure probability is calculated by the ratio of failure sample number to total sample number [20]. With the characteristics of easy realization and high accuracy [21], Monte Carlo Simulation (MCS) is the most commonly used numerical simulation method, which is not affected by distribution of random variables and types of performance functions. But accurate reliability analysis often requires a lot of samples, and the response values at these samples usually need computer simulation or real experiments to obtain. Hence, the computational cost of MCS is usually very high [22]. To improve the computational efficiency of MCS, the important sampling (IS) strategy can be adopted. By relocating the random sampling center to increase the probability of the sample point falling into the failure region, the IS strategy reduces the number of sample points needed to calculate the failure probability, thus the computational costs can be reduced heavily [23,24]. Besides the IS strategy, other methods to improve the efficiency of MCS include Line Sampling [25,26], Directional Simulation [27,28] and Subset Simulation [29,30] et al.

    In surrogate-assisted RBDO, MCS is most commonly used to calculate the failure probability and corresponding gradient. In MCS, a group of random samples are generated according to the probability distribution of random variables, and then their responses are evaluated to judge whether the failure event occurs. The ratio of the failure number to the total number is regarded as the failure probability. Using MCS to calculate the failure probability is as follows:

    $ P\left(g\right(X)\le 0) = {\int }_{g\le 0}{f}_{X}\left(x\right)dx = {\int }_{-\infty }^{+\infty }I\left[{g}_{X}\right(x\left)\right]{f}_{X}\left(x\right)dx = \frac{1}{N}{\sum }_{j = 1}^{N}I\left[{g}_{X}\right({x}^{j}\left)\right] $ (3)

    In Eq. (3), $ N $ is the size of the Monte Carlo population; $ I\left(x\right) $ is the indicator function of$ x $; if $ {g}_{X}\left(x\right)\le 0 $, $ I\left[{g}_{X}\right(x\left)\right] = 1 $, if not, $ I\left[{g}_{X}\right(x\left)\right] = 0 $.

    For random variable$ x $ which obeys the normal distribution, the failure probability gradient$ \frac{\partial P\left(\mu \right)}{\partial {\mu }_{i}} $at its mean point $ \mu $ is calculated as follows:

    $ \frac{\partial P\left({\mu }_{X}\right)}{\partial {\mu }_{i}} = \frac{1}{N}{\sum }_{j = 1}^{N}\frac{I\left[{g}_{X}\right({x}^{j}\left)\right]}{{f}_{X}\left({x}^{j}\right)}\frac{\partial {f}_{X}\left({x}^{j}\right)}{\partial {\mu }_{i}} = \frac{1}{N}{\sum }_{j = 1}^{N}\frac{I\left[{g}_{X}\right({x}^{j}\left)\right]({x}_{i}^{j}-{\mu }_{i})}{{\sigma }_{i}^{2}} $ (4)

    The test points$ {x}^{j}, i = 1, \cdot \cdot \cdot, N $ in Eq. (4) are the same as that used for estimating the failure probability $ P\left(g\right(X)\le 0) $. In other words, the calculation of $ \frac{\partial {P}_{j}\left({\mu }_{X}^{k}\right)}{\partial {\mu }_{X}} $ does not require additional performance function evaluation. Details about the Eq. (4) are in references [31]. It's worth noting that, if the random variable obeys other distribution type, Rosenblatt transformation [32] or Nataf transformation [33] can be used to transform them to the normal distribution.

    From the mathematical model of RBDO in Eq. (1), it can be seen that the solution process of RBDO is divided into two stages: reliability analysis stage to calculate whether the failure probability of the current design point meets the reliability requirement and design optimization stage to find the optimal solution that meets the probability constraint. To handle the coupling relationship between the two stages, three types of methods are formed: double loop methods, single loop methods and decoupling methods. The characteristics of these three methods are compared in Table 1. Generally, the double loop methods are easy to implement, but due to the multiplication of the number of iterations in both design optimization and reliability analysis loops, the computational cost of double loop methods is very high. In single loop methods, the reliability analysis loop is approximated by its Karush–Kuhn–Tucker (KKT) optimality conditions. Therefore, the efficiency of single-loop methods is very high for linear and moderate nonlinear performance functions. But due to the large error caused by approximation, the single loop methods have bad performance for highly nonlinear problem. In decoupling methods, reliability analysis and design optimization are performed sequentially, therefore these methods can achieve the balance of accuracy and efficiency.

    Table 1.  Comparison of double loop methods, single loop methods and decoupling methods.
    Methods Double loop methods Single loop methods Decoupling methods
    Advantages Easy to implement High Efficiency Achieve the balance of accuracy and efficiency
    Disadvantages Low efficiency Poor performance for highly nonlinear problem Performance is affected by optimization algorithm
    Examples [34,35,36,37,38,45,46] [40,41,42,44] [4,47,48,49,50,51,52,53,54,55,56]

     | Show Table
    DownLoad: CSV

    Reliability index approach (RIA) [34,35] and performance measure approach (PMA) [36,37,38] are the most commonly used double loop methods. Because reliability analysis is needed at each iteration point of design optimization, the calculation efficiency of the double loop methods is very low [39]. Using the Karush Kuhn Tucker (KKT) condition instead of the probabilistic constraint to directly solve the RBDO problem is the most commonly used single loop methods [40,41,42]. Although the single loop method has high efficiency, Aoues shows that the stability of the single loop strategy is insufficient through standard examples [43].

    Different from the double loop methods and single loop methods, the decoupling methods use the deterministic constraints to approximate the probability constraint sequentially. Li proposed one of the earliest decoupling strategies to solve RBDO problem by linear approximation of reliability index [47]. Then some scholars introduced MPP [48] and developed approximate decoupling strategies such as adaptive sequential linear programming algorithms [49,50] to balance accuracy, efficiency and convergence. In addition, Wu put forward the equivalent probabilistic constraint based on safety factor, which simplifies the solving process of performance function value and improves the solving efficiency [51]. Du proposed the well-known sequential optimization and reliability assessment (SORA) method, which decouples the RBDO process into a sequential single loop process to improve the efficiency of probabilistic design [52]. Other decoupling methods in RBDO include the convex linear method [55], saddle point approximation method [56], optimal shifting vector [4] etc.

    In addition, to alleviate the computational time caused by solution in both physical space and normalized space, hybrid method (HM) [57,58], improved hybrid method (IHM) [59,60], optimum safety factor (OSF) method [61,62], robust hybrid method (RHM) [61,62,63,64,65] and hybrid modified method [66] are developed. These methods solved the optimization problem and the reliability problem simultaneously in the hybrid design space (HDS) [63]. Therefore, the huge calculation time can be reduced.

    In reliability analysis or design optimization, various optimization algorithms are used to calculate the MPP and design point. Commonly used optimization algorithms include sequential approximate programming (SAP), active set method, trust region algorithm, penalty function method and so on.

    In addition, evolutionary methods and swarm intelligence algorithms are also used in RBDO. Garakani [67] used adaptive Metropolis algorithm to obtain data and combined multi-gene genetic programming (MGGP) model with MCS to calculate the failure probability. Yadav established the robust design optimization (RDO) and RBDO model of trusses, and then solved them by particle swarm optimization (PSO) algorithm [68]. Tong [69] proposed a new hybrid reliability analysis algorithm based on PSO-optimized Kriging model. By comparing the calculation results of PSO-optimized Kriging model with the original model, it is verified that this method can greatly reduce the number of sample points and improve the solution efficiency. Aiming at minimizing maintenance cost under reliability constraints, Chen proposed a collaborative PSO-Dynamic Programming (co PSO-DP) method for multi-stage and multi scheme maintenance [70]. In order to reduce the weight and cost of crane metal structure (CMS), Fan established a discrete double loop RBDO model [71]. In the inner loop, Latin hypercube sampling (LHS) and MCS are used to analyze the reliability, and ant colony optimization (ACO) algorithm is used in the outer loop to solve the optimization results satisfying the deterministic and probabilistic constraints. Antos [72] combined ant colony algorithm with first-order reliability method to form nested optimization cycle, and applied it to the RBDO of geosynthetics reinforced earth retaining wall. Okasha used the improved firefly algorithm to solve the RBDO problem of truss structures with discrete design variables, which can obtain a reasonable solution with a reasonable amount of computations [73].

    In evolutionary methods and swarm intelligence algorithms, there are no special requirements on the mathematical properties (such as convexity, continuity or explicit definition) of objective function and constraints in the optimization process. Therefore, evolutionary methods and swarm intelligence algorithms may be the research hotspot of RBDO in the future.

    The evaluation of implicit performance function is an important part of reliability analysis and RBDO. If the real response value of implicit performance function is called directly during reliability analysis and design optimization, the computational cost is unacceptable. Therefore, the introduction of surrogate models in reliability analysis and RBDO has become a research hotspot.

    Constructed by interpolation or fitting of representative sample points, surrogate models have the characteristics of simple structure and high computational efficiency. Therefore, surrogate models have been widely used to approximate the implicit performance function in engineering. Most commonly used surrogate models include polynomial response surfaces (PRS) [36], Kriging approximation models [74,75,76], radial basis functions (RBF) [77], and support vector machine (SVM) or support vector regression (SVR).

    Polynomial response surface model is also called polynomial regression model or polynomial approximation model, which is simple and easy to implement. Thus, any implicit function can be expressed by polynomial approximation. Commonly used second order polynomial response surface model is formulated as follows [36,78]:

    $ \widehat{g}\left(x\right) = {a}_{0}+{\sum }_{i = 1}^{n}{a}_{i}{x}_{i}+{\sum }_{i = 1}^{n}{\sum }_{j\ge 1}^{n}{a}_{ij}{x}_{i}{x}_{j} $ (5)

    In Eq. (5), $ {x}_{i} $ is the ith component of the n dimension design variable; $ {a}_{0} $ is the constant term; $ {a}_{i} $ is the coefficient of first term; $ {a}_{ij} $ is the coefficient of quadratic term (also known as cross term).

    Kriging model consists of a polynomial response function model and a Gaussian random process, which is formulated as follows:

    $ \widehat{y}\left(x\right) = F\left(\beta , x\right)+Z\left(x\right) $ (6)

    In Eq. (6), $ F\left(\beta, x\right) $ is the global polynomial response surface model with weight coefficient$ \beta $; $ Z\left(x\right) $ is a nonparametric random process model with 0 as mean value and $ {\sigma }^{2} $ as variance [79,80]. In Kriging model, an indicator of a priori uncertainty prediction can be provided, thus it is widely used in engineering problems [81].

    Taking the Euclidean distance between the predicted points and the sample point as the design variable, RBF model is constructed by linear combination of radial symmetric kernel functions. The RBF model is expressed as follows [77,82]:

    $ \stackrel{\wedge }{y\left(x\right)} = {\sum }_{k = 1}^{n}{\omega }_{k}{\psi }_{k}\left(‖x-{x}_{k}‖\right) $ (7)

    In Eq. (7), n is the number of sample points; $ {\omega }_{k} $ is the weight coefficient; $ \psi \left(‖x-{x}_{k}‖\right) $ is the basis function centered on sample $ {x}_{k} $; $ ‖x-{x}_{k}‖ $ is the Euclidean distance between the predicted points and the sample points. For highly nonlinear problems, good fitting performance can usually be observed using RBF model [77].

    Support vector machine (SVM) is a supervised learning model based on structural risk minimization criteria. SVR model is a specific form of support vector machine in the prediction field. SVR realizes the approximate of the low-dimensional spatial problem by mapping the parameter combination vector to the high-dimensional space and constructing the regression function in the high-dimensional space [83]. SVR model is expressed as follows:

    $ \stackrel{\wedge }{p\left(x\right)} = 〈w\cdot {\mathit \Phi } \left(x, {x}_{k}\right)〉+b $ (8)

    In Eq. (8), $ 〈w\cdot {\mathit \Phi } \left(x, {x}_{k}\right)〉 $ is the inner product of hyperparameter$ w $and support vector regression kernel function$ {\mathit \Phi } \left(x, {x}_{k}\right) $; $ b $is the undetermined coefficient.

    In addition to the above models, some achievements are also made in variable fidelity (VF) approximation models and ensemble approximation models. Variable fidelity model (also termed as multi-fidelity model) is an approximate model constructed by fusion of high and low fidelity samples. In VF model, the global approximation trend of implicit function is reflected by low fidelity model, and the accuracy is guaranteed by introducing a small number of high-fidelity samples [84,85,86,87]. As shown in Figure 1, the variable fidelity model $ {f}_{v}\left(x\right) $ shows good fitting performance to the high-fidelity model $ {f}_{h}\left(x\right) $ by fusing the low fidelity model $ {f}_{l}\left(x\right) $ and four high fidelity samples.

    Figure 1.  Description of variable fidelity model.

    The VF model is expected to fuse the advantages of LF and HF models and thus become a new choice in engineering. Nevertheless, how to determine the variable fidelity modeling framework and how to quantitatively compare the computational cost of HF model, LF model and VF model still need to be researched [88].

    Ensemble model is another choice which expects to combines the advantage of multiple single surrogate models [89,90,91,92]. The modeling strategies of ensemble model can be divided into two categories: weighting and voting [90]. The former is based on the prediction accuracy of single models, and a larger weight coefficient is assigned to the model with higher accuracy. The weight coefficients of each single model in the ensemble model is added up to 1 to ensure the accuracy of the prediction value of the ensemble model [89,92]. Voting strategy can be regarded as a special weighting strategy, which is usually used in the case of multiple iterations in modeling or optimization. The core is to set the weight of the model with the highest precision to 1, and the weights of other models to 0. In single surrogate models, the modeling performance usually relies on the selection of samples. But the ensemble model can avoid these shortcomings, thus it is able to achieve a robust modeling effect [90].

    Construction of surrogate model depends on the selection of samples, which can be divided into one-shot sampling methods and sequential sampling methods [94]. Commonly used one-shot sampling methods include full factorial design (FFD) [94,95], orthogonal design [96,97], uniform design [98,99], Latin hypercube design (LHD) [100,101], etc. Sequential sampling method is to establish the initial surrogate model by one-shot sampling first, and then update the surrogate model by adding samples until the required accuracy is achieved.

    In full factorial design, all levels of each factor are combined to carry out the design of experiments. However, with the increase of design variables and levels, the number of samples required will increase exponentially, which cannot be acceptable in engineering. Therefore, this method is only suitable for the case of fewer design factors and levels. In order to reduce the computational cost of full factorial design, some representative samples instead of all FFD samples can be selected in orthogonal design or uniform design. Furthermore, Latin hypercube design can also be adopted to ensure the representativeness of samples and reduce the repeatability of samples through the layered treatment in the whole design space. Figure 2 shows the sample distribution of 2-factor-3-level full factor experiment design (9 samples), 3-factor-3-level orthogonal experiment design (9 samples) and 9-point Latin hypercube design.

    Figure 2.  Sample distribution of one-shot sampling methods.

    One-shot sampling methods is easy to implement, but the accuracy of the surrogate model cannot be guaranteed. Increasing the number of samples will increase the computational cost and even may cause overfitting. On the contrary, fewer samples will affect the accuracy of surrogate model. Therefore, it is necessary to add sequential samples to update the surrogate model in reliability analysis and RBDO. Sequential sampling methods is a strategy which improves the model accuracy by dividing the modeling process into several stages. The flowchart of sequential sampling methods is shown in Figure 3. First, the initial surrogate model is built by one-shot sampling, and then the surrogate model is updated by adding samples according to some criteria until the required accuracy is achieved.

    Figure 3.  Flowchart of sequential sampling.

    Figure 4 further describes the process of sequential sampling. $ f\left(x\right) $ is the true performance function which needs to be approximated. $ {f}_{0}\widehat{(}x) $ is the initial surrogate model constructed by initial samples (black circles) generated from one-shot sampling method. Using the sequential samples (black boxes) to update the surrogate model, the final surrogate mode $ {f}_{s}\widehat{(}x) $ with high approximating accuracy is acquired.

    Figure 4.  Process of sequential sampling.

    The selection of sequential samples can be divided into following methods: error-based methods, methods based on distance to existing samples and methods of sampling near constrained boundaries (Seen in Table 2). The error-based methods can guarantee the accuracy of the surrogate model, but it is difficult to accurately evaluate the modeling error with limit samples. The method based on the distance to the existing samples can evenly distribute the sample points in the design domain. But for highly nonlinear or discontinuous problems, these methods may have poor performance. Sampling near the constraint boundary can improve the fitting accuracy of the constraint boundary, but if the constraint boundary is approximated inaccurately, many samples will be wasted. In engineering, these three sampling methods are often combined to obtain the comprehensive advantages [102,103,104,105].

    Table 2.  Sequential sampling methods.
    Methods Error-based methods Methods based on distance to existing samples Methods of sampling near constrained boundaries
    Advantages Guarantee the modeling precision Ensure the uniformity of sample distribution Ensure the fitting accuracy of the constrained boundary
    Disadvantages Accurate error is difficult to assess Poor effect for highly nonlinear or discontinuous problem Sampling at inaccurate constraint boundary may cause waste of samples
    Examples [106,107,108,109,110] [93,111,112] [113,114,115]

     | Show Table
    DownLoad: CSV

    The accuracy of the surrogate model reflects the fitting degree between the predicted response function and the real response function. The following error indexes can be used in accuracy evaluation of surrogate model [116]:

    (1) Multiple correlation coefficient $ {R}^{2} $

    $ {R}^{2} $ is used to evaluate the relative error of the surrogate model in the whole design space [117]. The larger the value of $ {R}^{2} $, the higher the accuracy of the surrogate model is.

    $ {R}^{2} = 1-\frac{{\sum }_{i = 1}^{m}{\left({y}_{i}-{\widehat{y}}_{i}\right)}^{2}}{{\sum }_{i = 1}^{m}{\left({y}_{i}-{\stackrel{̄}{y}}_{i}\right)}^{2}} = 1-\frac{MSE}{Var} $ (9)

    (2) Relative Average Absolute Error (RAAE)

    $ RAAE $ is used to evaluate the global relative error of the surrogate model. The smaller the value of $ RAAE $, the smaller the global relative error is.

    $ RAAE = \frac{{\sum }_{i = 1}^{m}\left|{y}_{i}-{\widehat{y}}_{i}\right|}{m\times STD} $ (10)

    (3) Root Mean Squared Error (RMSE)

    RMSE is used to evaluate the closeness between the predicted value and the true value [118]. The smaller the value of RMSE, the higher the accuracy of the surrogate model is.

    $ RMSE = \sqrt{\left\{{\sum }_{i = 1}^{m}{\left({y}_{i}-{\widehat{y}}_{i}\right)}^{2}\right\}/m} $ (11)

    (4) Relative Root Mean Squared Error (RRMSE)

    RRMSE is used to indicate the degree of accuracy improvement of the surrogate model. The smaller the value of $ RRMSE $, the higher the degree of accuracy improvement of the surrogate model is.

    $ RRMSE = \frac{1}{STD}\sqrt{\frac{{\sum }_{i = 1}^{m}{\left({y}_{i}-{\widehat{y}}_{i}\right)}^{2}}{m}} $ (12)

    (5) Relative Maximum Absolute Error (RMAE)

    RMAE is used to evaluate the local prediction error of the surrogate model. The smaller the RMAE value, the smaller the local prediction error of the surrogate model is.

    $ RMAE = \frac{\underset{i = 1, \cdots , m}{max}\left|{y}_{i}-{\widehat{y}}_{i}\right|}{STD} $ (13)

    (6) Generalized Mean Square Cross-validation Error ($ GMSE $)

    GMSE is used to evaluate the prediction error of the surrogate model with limited samples. The smaller the value of $ GMSE $, the smaller the prediction error of the surrogate model is.

    $ GMSE = \frac{1}{m}{{\sum }_{j = 1}^{m}\left({f}_{j}-{{\widehat{f}}_{j}}^{\left(-j\right)}\right)}^{2} $ (14)

    In equations (9)-(14), $ m $ is the number of samples used for model accuracy evaluation; $ {y}_{i} $ is the actual response value of performance function, and $ \widehat{y} $ is the predicted value obtained by the surrogate model; $\bar y = \frac{1}{m}\sum\limits_{{y_i}}^m {y{}_i} $; $ {{\widehat{f}}_{j}}^{\left(-j\right)} $ is the predicted value at point $ {x}^{\left(j\right)} $ by the surrogate model constructed using the remaining$ m-1 $sample points except point $ \left({x}^{\left(j\right)}, {f}_{j}\right) $. $ MSE $ is the mean square error of the experimental data, $ Var $ is the variance of the experimental data, and $ STD $ is the standard deviation of the experimental data. $ MSE $, $ Var $ and $ STD $ are calculated as follows:

    $ MSE = \frac{{\sum }_{i = 1}^{m}{\left({y}_{i}-{\widehat{y}}_{i}\right)}^{2}}{m},Var = \frac{{\sum }_{i = 1}^{m}{\left({y}_{i}-\stackrel{̄}{y}\right)}^{2}}{m},STD = \sqrt{Var} $ (15)

    In recent decades, many researches have been performed in surrogate-assisted RBDO methods, especially in sequential sampling based RBDO methods. The sequential sampling methods for surrogate model are reviewed in previous section. Different from the sequential sampling methods in surrogate model, some characteristics of RBDO solution process are considered. For example, sequential sampling methods on improving the accuracy of failure probability calculation [103,119], using MPP for sequential sampling [120], using the samples in the key area of reliability analysis or RBDO [122] and using MCS samples to build surrogate model [22] are also considered in surrogate-assisted RBDO.

    The sequential sampling methods in surrogate-assisted RBDO can be divided into global modeling methods and local modeling methods. It's worth noting that, the global modeling methods can be used in RBDO or other optimization problems, but the local modeling methods can only be used in RBDO. In global modeling methods, accurate performance function boundaries are first approximated in the whole design space (Figure 5(a)), and then RBDO is conducted to find the optimal design. Instead, accurate fitting is only needed in the key area of RBDO (usually near the iterative design point) in local modeling methods (Figure 5(b)). The core of local modeling methods is to update the surrogate model and carry out the design optimization sequentially, as shown in Figure 5 (b) [102].

    Figure 5.  Sample distribution of global modeling method and local modeling method [102].

    The sample distribution of global modeling methods and local modeling methods are compared in Figure 5. The dotted line is the real performance function curve $ f({x}_{1}, {x}_{2}) $; the solid line is the prediction curve of the surrogate model $ \widehat{f}({x}_{1}, {x}_{2}) $; the red "*" is the sample used to construct the surrogate model, and the blue "+" is the optimization iterative design point of RBDO; the green ellipse in Figure 5 (b) is the local sampling region. It can be seen that the global modeling methods fit the boundary of the whole performance function accurately, while the local modeling methods only fit the key area of the optimization iteration.

    The global modeling methods in RBDO can be divided into the global modeling methods based on one-shot sampling and the global modeling methods based on sequential sampling. Using one-shot sampling, it is difficult to balance the solution precision and computational cost, so current global modeling methods are mostly based on sequential sampling. The basic flowchart of global modeling method in RBDO is shown in Figure 6. After the initial sample set and design point are determined, the initial surrogate model is constructed. And then the surrogate model is updated by global sequential sampling until the accuracy satisfies the requirement. After that, the accurate global surrogate model is used to replace the implicit objective function and performance function in RBDO. Finally, the RBDO problem is solved by double loop methods, single loop methods or decoupling methods.

    Figure 6.  The flowchart of global modeling methods in RBDO.

    Following describes the commonly used global modeling methods: Constraint boundary sampling (CBS). Constraint boundary sampling is developed to realize the accurate approximation of the constraint boundary in the whole design space [113]. New samples are mainly selected on the approximate constraint boundary. When the accuracy of the global surrogate model satisfies the requirement, RBDO is carried out. The sequential sampling criteria in CBS are as follows:

    $ CBS\left(x\right) = \left\{Nc=1ϕ(ˆμgc(x)σgc(x))Dˆμgc(x)0,i0others
    \right. $
    (16)

    In CBS, samples locating near the predicted constrained boundary will be preferred.

    The global modeling method can fit the constraint boundary in the whole design space well, but there are always some inactive samples in RBDO (Such as the samples located on the lower left quarter in Figure 5(a)), which will inevitably cause waste of computational resources. Therefore, the local modeling methods to fit the key region of design space is proposed. The flowchart of local modeling methods is shown in Figure 7. Different from global sampling methods, the sequential samples are mainly selected in a small local region around the current design which is calculated by double loop methods, single loop methods or decoupling methods. Therefore, the RBDO process and sequential sampling are conducted sequentially.

    Figure 7.  The flowchart of local modeling methods in RBDO.

    Following is a brief introduction of the representative local modeling method LAS (local adaptive sampling method). In LAS, the samples are preferentially selected near the constraint boundaries around the current design point [102]. The size of local sampling region is determined according to the target reliability and nonlinearity of the performance functions, which is shown as:

    $ R = 1.2{\beta }^{t}+0.3nc{\beta }^{t} = \left(1.2+0.3nc\right){\beta }^{t} \\ nc = \frac{2}{\pi }\mathit{arctan}\left(\mathit{max}\left(‖{\sigma }_{i}^{2}‖\right)\right), i = 1, \cdots , N \\ {\sigma }_{i}^{2} = variance\left({\mathit \nabla } {\widehat{g}}_{i}\left({x}^{1}\right), \cdots , {\mathit \nabla } {\widehat{g}}_{i}\left({x}^{M}\right)\right) $ (17)

    Where $ nc $ is used to quantify the nonlinearity of the performance functions; $ {\mathit \nabla } {\widehat{g}}_{i}\left(x\right) $ is the predicted gradient value at $ x $ for the ith probabilistic constraint. $ \left({x}^{1}, \cdots, {x}^{M}\right) $ are the M testing points evenly located within the $ {\beta }^{t} $-sphere region. $ N $is the number of probabilistic constraints. Seen from Eq. (17), a larger local sampling region is assigned to performance function with larger target reliability and higher nonlinearity.

    After the local sampling region is determined, MSE sampling criterion and CBS criterion are introduced to select the sequential samples. The detailed sequential sampling criterion in LAS is as follows:

    $ LAS = \left\{Ni=1σiD,No constraint boundary in local sampling regionCBS,otherwise
    \right. $
    (18)

    In Eq. (18), if no performance function boundary is contained in the local sampling region, the prediction error and distance to the existing samples are used to select new samples. Otherwise, CBS sampling criterion in Eq. (16) is adopted.

    To compare the performance of global modeling method and local modeling method, a two-dimensional RBDO problem with three probabilistic constraints is introduced, which is formulated as follows:

    $ \text{find}\;{\mathtt{μ }}_{X} = [{\mu }_{{X}_{1}}, {\mu }_{{X}_{2}}] \\ \text{min}\;{\mathtt{μ }}_{{X}_{1}}+{\mu }_{{X}_{2}} \\ \text{s.t. Prob}\left({g}_{i}(X\right)\le 0)\le {\mathit \Phi } (-{\beta }_{i}^{t})\text{}i = \mathrm{1, 2}, 3 \\ \text{}0\le {\mathtt{μ }}_{{X}_{1}}\le 10, \text{}0\le {\mathtt{μ }}_{{X}_{2}}\le 10, \\ {g}_{1}(X) = 1-{X}_{1}^{2}{X}_{2}/20 \\ {g}_{2}(X) = ({X}_{1}+{X}_{2}-5{)}^{2}/30+({X}_{1}-{X}_{2}-12{)}^{2}/120-1 \\ {g}_{3}(X) = 1-80/({X}_{1}^{2}+8{X}_{2}+5) \\ {X}_{i} \sim N({\mu }_{{X}_{i}}, 0.{3}^{2}),i = \mathrm{1, 2} \\ {\mu }_{X}^{0} = \left[\text{5, 5}\right] $ (19)

    Figure 8 shows the locations of sample points when using CBS and LAS to solve this problem. Black "o" is the initial samples using LHS method and red "x" is the sequential samples; blue "+" is the design point. $ {d}^{0} $ is the initial design point and $ {d}^{opt} $ is the optimal design point. As can be seen, both the CBS method and LAS method can obtain the optimal design $ {d}^{opt} $. The surrogate model using CBS method has good fit performance in the whole design space and most sequential sample points are located near the constraint boundary (Seen in Figure 8(a)). Differently, most of the sequential sample points in LAS are concentrated in the small local region around current iterative design points (Blue ellipse in Figure 8(b)). Therefore, the fitting capability of surrogate model is weak in the upper right quarter of the design space. Because sequential sampling is avoided in the meaningless region of RBDO process, LAS has higher efficiency. It's worth noting that, if the target reliability changes, the sequential sampling process of LAS method will be conducted again. Therefore, the surrogate model constructed by LAS cannot be reused (Seen in Figure 8(c)).

    Figure 8.  The distribution of sample points for Numerical example.

    Table 3 shows the comparison of global modeling methods and local modeling methods. In global modeling methods, an accurate global surrogate model is built in the whole design space, therefore this model can also be used when the target reliability changes. But when the target reliability is fixed, the efficiency is usually lower than local modeling methods (Seen in Figure 8). On the other hand, the local modeling method is more efficient for problem with fixed target reliability. But when the target reliability changes, the local sampling region and corresponding sequential sample points will change, which means different surrogate models must be built for problems with different target reliability.

    Table 3.  Comparison between global modeling methods and local modeling methods.
    Method Global modeling methods Local modeling methods
    Advantages Ensure the modeling accuracy in the whole design domain; No need to remodel when the target reliability changes High utilization rate of samples and high fitting accuracy of key areas
    Disadvantages Modeling efficiency is usually lower than local modeling methods Remodeling is needed when the target reliability changes
    Example [22,103,113,114,115,122,123,124,125,126,127] [102,104,128,129,130,131]

     | Show Table
    DownLoad: CSV

    In this paper, the surrogate-assisted RBDO methods are reviewed. Commonly used reliability analysis methods, RBDO methods, surrogate models and corresponding sampling and accuracy evaluation methods are summarized and discussed. Then the surrogate-assisted RBDO methods are divided into the global modeling methods and local modeling methods. The advantages and dis advantages of these two methods are compared.

    (1) This paper introduces the mathematical model of RBDO, summarizes the existing reliability analysis methods and RBDO methods. Different RBDO methods are classified and compared.

    (2) This paper summarizes the commonly used surrogate model, sampling method and accuracy evaluation methods of surrogate models. Different sampling methods are classified and compared.

    (3) This paper divided the surrogate-assisted RBDO methods into the global modeling methods and local modeling methods. Using a representative numerical example, the advantages and disadvantages of these two modeling methods are compared.

    Although many surrogate-assisted RBDO methods have been developed, there are still some research space to further strengthen the application of these methods in engineering. Future researches can be focused on the following aspects:

    (1) Quantification of modeling error of surrogate model

    Generally, the number of samples used to build the surrogate model is finite, thus the prediction accuracy of the surrogate model cannot be well guaranteed. Meanwhile, in existing researches, the modeling error of surrogate model is mainly used in sequential sampling. This strategy can achieve the optimal RBDO solution for general functions, but it may have large error for multimodal functions, or even cannot meet the reliability requirements. Therefore, it is of great significance to quantify the modeling error and construct its conservative model as an alternative to the implicit performance function, which finally achieve the performance improvement on the premise of ensuring the reliability requirements.

    (2) Determination of high-fidelity samples and low fidelity samples in variable fidelity model

    Commonly used variable fidelity methods are based on the situation that the function form (often from empirical formula, etc.) of the low fidelity model is known. In view of the unknown function form of low fidelity model, it is very important to allocate the high and low fidelity samples reasonably in RBDO process. In addition, the study of the variable fidelity method based on the surrogate model will also be a useful supplement.

    (3) Construction of surrogate model for high dimensional RBDO problem with limited samples

    The existence of "dimension disaster" makes the computational cost of existing RBDO methods unacceptable, which not only exists in the construction of surrogate model, but also in the process of reliability analysis and design optimization. In order to acquire an accurate and efficient RBDO solution, the problem dimension must be limited. Effective variable selection methods, high dimensional model representation methods, high dimensional reliability analysis methods and high dimensional optimization methods will be future research hotspots.

    (4) Construction of classification model to balance the precision and cost in RBDO

    Besides using surrogate models to accurately approximate the implicit objective and performance functions, introduction of the classification method such as support vector machine is another viable option. However, the existing support vector machine method is commonly confronted with precision problem because of lack of real function response information. Therefore, it is necessary to develop a more effective classification model to balance the precision and cost in RBDO.

    This research was funded by National Natural Science Foundation of China (Grant No. 51905492), Key Scientific and Technological Research Projects in Henan Province (Grant No. 202102210089, 202102210274), Innovative Research Team (in Science and Technology) in University of Henan Province (Grant No. 20IRTSTHN015).

    [1] Alzheimer A, Stelzmann RA, Schnitzlein HN, et al. (1995) An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin Anat 8: 429-431. doi: 10.1002/ca.980080612
    [2] (2013) 2013 Alzheimer's disease facts and figures. Alzheimers Dement 9: 208-245. doi: 10.1016/j.jalz.2013.02.003
    [3] Brookmeyer R, Johnson E, Ziegler-Graham K, et al. (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3: 186-191. doi: 10.1016/j.jalz.2007.04.381
    [4] Martins RN, Robinson PJ, Chleboun JO, et al. (1991) The molecular pathology of amyloid deposition in Alzheimer's disease. Mol Neurobiol 5: 389-398. doi: 10.1007/BF02935560
    [5] Masters CL, Multhaup G, Simms G, et al. (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. Embo J 4: 2757-2763.
    [6] Schweers O, Mandelkow EM, Biernat J, et al. (1995) Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sci U S A 92: 8463-8467. doi: 10.1073/pnas.92.18.8463
    [7] Goedert M, Jakes R, Spillantini MG, et al. (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383: 550-553. doi: 10.1038/383550a0
    [8] Villemagne VL, Pike KE, Darby D, et al. (2008) Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia 46: 1688-1697. doi: 10.1016/j.neuropsychologia.2008.02.008
    [9] Chien DT, Bahri S, Szardenings AK, et al. (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis 34: 457-468.
    [10] Maruyama M, Shimada H, Suhara T, et al. (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79: 1094-1108. doi: 10.1016/j.neuron.2013.07.037
    [11] Rentz DM, Parra Rodriguez MA, Amariglio R, et al. (2013) Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review. Alzheimers Res Ther 5: 58. doi: 10.1186/alzrt222
    [12] Baumgart M, Snyder HM, Carrillo MC, et al. (2015) Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement.
    [13] Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10: 819-828. doi: 10.1016/S1474-4422(11)70072-2
    [14] Selkoe DJ (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271: 18295-18298. doi: 10.1074/jbc.271.31.18295
    [15] Glenner GG, Wong CW (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122: 1131-1135. doi: 10.1016/0006-291X(84)91209-9
    [16] Mann DM, Esiri MM (1989) The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci 89: 169-179. doi: 10.1016/0022-510X(89)90019-1
    [17] Jorm AF, Korten AE, Henderson AS (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76: 465-479. doi: 10.1111/j.1600-0447.1987.tb02906.x
    [18] Hebert LE, Weuve J, Scherr PA, et al. (2013) Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80: 1778-1783. doi: 10.1212/WNL.0b013e31828726f5
    [19] (2015) 2015 Alzheimer's disease facts and figures. Alzheimers Dement 11: 332-384. doi: 10.1016/j.jalz.2015.02.003
    [20] Lukiw WJ (2004) Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem Res 29: 1287-1297. doi: 10.1023/B:NERE.0000023615.89699.63
    [21] Smith MA, Nunomura A, Lee HG, et al. (2005) Chronological primacy of oxidative stress in Alzheimer disease. Neurobiol Aging 26: 579-580; discussion 587-595. doi: 10.1016/j.neurobiolaging.2004.09.021
    [22] Overmyer M, Helisalmi S, Soininen H, et al. (1999) Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue. Acta Neuropathol (Berl) 97: 383-392. doi: 10.1007/s004010051002
    [23] Currais A (2015) Ageing and inflammation - A central role for mitochondria in brain health and disease. Ageing Res Rev 21: 30-42. doi: 10.1016/j.arr.2015.02.001
    [24] Mielke MM, Vemuri P, Rocca WA (2014) Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clin Epidemiol 6: 37-48.
    [25] Chapman RM, Mapstone M, Gardner MN, et al. (2011) Women have farther to fall: gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women. J Int Neuropsychol Soc 17: 654-662. doi: 10.1017/S1355617711000452
    [26] Green PS, Simpkins JW (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18: 347-358. doi: 10.1016/S0736-5748(00)00017-4
    [27] Jones KJ, Brown TJ, Damaser M (2001) Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons. Brain Res Brain Res Rev 37: 372-382. doi: 10.1016/S0165-0173(01)00107-2
    [28] Wise PM, Dubal DB, Wilson ME, et al. (2001) Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology 142: 969-973.
    [29] Strittmatter WJ, Saunders AM, Schmechel D, et al. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90: 1977-1981. doi: 10.1073/pnas.90.5.1977
    [30] Saunders AM, Strittmatter WJ, Schmechel D, et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472. doi: 10.1212/WNL.43.8.1467
    [31] Corder EH, Saunders AM, Strittmatter WJ, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923. doi: 10.1126/science.8346443
    [32] McGeer PL, Walker DG, Pitas RE, et al. (1997) Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta- amyloid protein activation of complement in vitro. Brain Res 749: 135-138. doi: 10.1016/S0006-8993(96)01324-8
    [33] Prince JA, Zetterberg H, Andreasen N, et al. (2004) APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology 62: 2116-2118. doi: 10.1212/01.WNL.0000128088.08695.05
    [34] Tiraboschi P, Hansen LA, Masliah E, et al. (2004) Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 62: 1977-1983. doi: 10.1212/01.WNL.0000128091.92139.0F
    [35] Lovestone S, Anderton BH, Hartley C, et al. (1996) The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific. Neuroreport 7: 1005-1008. doi: 10.1097/00001756-199604100-00010
    [36] Tesseur I, Van Dorpe J, Spittaels K, et al. (2000) Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am J Pathol 156: 951-964. doi: 10.1016/S0002-9440(10)64963-2
    [37] Arendt T, Schindler C, Bruckner MK, et al. (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci 17: 516-529.
    [38] Burkhardt MS, Foster JK, Laws SM, et al. (2004) Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. J Alzheimers Dis 6: 221-228.
    [39] Patterson CE, Todd SA, Passmore AP (2011) Effect of apolipoprotein E and butyrylcholinesterase genotypes on cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease. Pharmacogenomics J 11: 444-450. doi: 10.1038/tpj.2010.61
    [40] Petersen RC, Thomas RG, Grundman M, et al. (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352: 2379-2388. doi: 10.1056/NEJMoa050151
    [41] Bettens K, Sleegers K, Van Broeckhoven C (2013) Genetic insights in Alzheimer's disease. Lancet Neurol 12: 92-104. doi: 10.1016/S1474-4422(12)70259-4
    [42] Norton S, Matthews FE, Barnes DE, et al. (2014) Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol 13: 788-794. doi: 10.1016/S1474-4422(14)70136-X
    [43] Van Den Heuvel C, Thornton E, Vink R (2007) Traumatic brain injury and Alzheimer's disease: a review. Prog Brain Res 161: 303-316. doi: 10.1016/S0079-6123(06)61021-2
    [44] Solomon A, Kareholt I, Ngandu T, et al. (2007) Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology 68: 751-756. doi: 10.1212/01.wnl.0000256368.57375.b7
    [45] Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B (2015) Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci 9: 124.
    [46] Organization WH (2015) Global Strategy on Diet, Physical Activity and Health.
    [47] Warburton DE, Nicol CW, Bredin SS (2006) Health benefits of physical activity: the evidence. CMAJ 174: 801-809. doi: 10.1503/cmaj.051351
    [48] Beckett MW, Ardern CI, Rotondi MA (2015) A meta-analysis of prospective studies on the role of physical activity and the prevention of Alzheimer's disease in older adults. BMC Geriatr 15: 9. doi: 10.1186/s12877-015-0007-2
    [49] Reiner M, Niermann C, Jekauc D, et al. (2013) Long-term health benefits of physical activity--a systematic review of longitudinal studies. BMC Public Health 13: 813. doi: 10.1186/1471-2458-13-813
    [50] Angevaren M, Aufdemkampe G, Verhaar HJ, et al. (2008) Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev: CD005381.
    [51] Carter ND, Khan KM, McKay HA, et al. (2002) Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial. CMAJ 167: 997-1004.
    [52] Lynch NA, Ryan AS, Evans J, et al. (2007) Older elite football players have reduced cardiac and osteoporosis risk factors. Med Sci Sports Exerc 39: 1124-1130. doi: 10.1249/01.mss.0b013e3180557466
    [53] Vuori IM (2001) Dose-response of physical activity and low back pain, osteoarthritis, and osteoporosis. Med Sci Sports Exerc 33: S551-586; discussion 609-510. doi: 10.1097/00005768-200106001-00026
    [54] Tan ZS, Seshadri S, Beiser A, et al. (2005) Bone mineral density and the risk of Alzheimer disease. Arch Neurol 62: 107-111. doi: 10.1001/archneur.62.1.107
    [55] Zhang Y, Seshadri S, Ellison RC, et al. (2001) Bone mineral density and verbal memory impairment: Third National Health and Nutrition Examination Survey. Am J Epidemiol 154: 795-802. doi: 10.1093/aje/154.9.795
    [56] Yaffe K, Browner W, Cauley J, et al. (1999) Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc 47: 1176-1182. doi: 10.1111/j.1532-5415.1999.tb05196.x
    [57] Gunstad J, Paul RH, Cohen RA, et al. (2007) Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry 48: 57-61. doi: 10.1016/j.comppsych.2006.05.001
    [58] Gustafson D, Lissner L, Bengtsson C, et al. (2004) A 24-year follow-up of body mass index and cerebral atrophy. Neurology 63: 1876-1881. doi: 10.1212/01.WNL.0000141850.47773.5F
    [59] Jagust W, Harvey D, Mungas D, et al. (2005) Central obesity and the aging brain. Arch Neurol 62: 1545-1548.
    [60] Kivipelto M, Ngandu T, Fratiglioni L, et al. (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62: 1556-1560.
    [61] Whitmer RA, Gunderson EP, Barrett-Connor E, et al. (2005) Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. Bmj 330: 1360. doi: 10.1136/bmj.38446.466238.E0
    [62] Sohrabi HR, Bates KA, Weinborn M, et al. (2015) Bone mineral density, adiposity, and cognitive functions. Front Aging Neurosci 7: 16.
    [63] Koudinov AR, Berezov TT, Kumar A, et al. (1998) Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids. Clin Chim Acta 270: 75-84. doi: 10.1016/S0009-8981(97)00207-6
    [64] Koudinov AR, Koudinova NV, Kumar A, et al. (1996) Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: Associations with high density lipoproteins. Biochem Biophys Res Commun 223: 592-597. doi: 10.1006/bbrc.1996.0940
    [65] Eapen DJ, Kalra GL, Rifai L, et al. (2010) Raising HDL cholesterol in women. Int J Womens Health 1: 181-191.
    [66] Bates KA, Sohrabi HR, Rodrigues M, et al. (2009) Association of Cardiovascular Factors and Alzheimer's Disease Plasma Amyloid-beta Protein in Subjective Memory Complainers. J Alzheimers Dis 17: 305-318.
    [67] Atzmon G, Gabriely I, Greiner W, et al. (2002) Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol A Biol Sci Med Sci 57: M712-715. doi: 10.1093/gerona/57.11.M712
    [68] Crichton GE, Elias MF, Davey A, et al. (2014) Higher HDL cholesterol is associated with better cognitive function: the Maine-Syracuse study. J Int Neuropsychol Soc 20: 961-970. doi: 10.1017/S1355617714000885
    [69] Singh-Manoux A, Gimeno D, Kivimaki M, et al. (2008) Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife. The Whitehall II study. Arterioscler Thromb Vasc Biol 28: 1557-1563.
    [70] Ward MA, Bendlin BB, McLaren DG, et al. (2010) Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. Front Aging Neurosci 2.
    [71] Biessels GJ, Kappelle LJ (2005) Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33: 1041-1044.
    [72] Gatto NM, Henderson VW, St John JA, et al. (2008) Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 15: 627-641. doi: 10.1080/13825580802036936
    [73] Tomlinson DR, Gardiner NJ (2008) Glucose neurotoxicity. Nat Rev Neurosci 9: 36-45. doi: 10.1038/nrn2294
    [74] Craft S, Asthana S, Newcomer JW, et al. (1999) Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 56: 1135-1140. doi: 10.1001/archpsyc.56.12.1135
    [75] Craft S, Newcomer J, Kanne S, et al. (1996) Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 17: 123-130. doi: 10.1016/0197-4580(95)02002-0
    [76] Kulstad JJ, Green PS, Cook DG, et al. (2006) Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease. Neurology 66: 1506-1510. doi: 10.1212/01.wnl.0000216274.58185.09
    [77] Ibanez J, Izquierdo M, Arguelles I, et al. (2005) Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes Care 28: 662-667. doi: 10.2337/diacare.28.3.662
    [78] Knowler WC, Barrett-Connor E, Fowler SE, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403. doi: 10.1056/NEJMoa012512
    [79] Cotman CW, Berchtold NC, Christie LA (2007) Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 30: 464-472. doi: 10.1016/j.tins.2007.06.011
    [80] Kuipers SD, Bramham CR (2006) Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel 9: 580-586.
    [81] Neeper SA, Gomez-Pinilla F, Choi J, et al. (1996) Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 726: 49-56. doi: 10.1016/0006-8993(96)00273-9
    [82] Oliff HS, Berchtold NC, Isackson P, et al. (1998) Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res Mol Brain Res 61: 147-153. doi: 10.1016/S0169-328X(98)00222-8
    [83] Widenfalk J, Olson L, Thoren P (1999) Deprived of habitual running, rats downregulate BDNF and TrkB messages in the brain. Neurosci Res 34: 125-132. doi: 10.1016/S0168-0102(99)00051-6
    [84] Vaynman S, Ying Z, Gomez-Pinilla F (2004) Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci 20: 2580-2590. doi: 10.1111/j.1460-9568.2004.03720.x
    [85] Vaynman SS, Ying Z, Yin D, et al. (2006) Exercise differentially regulates synaptic proteins associated to the function of BDNF. Brain Res 1070: 124-130. doi: 10.1016/j.brainres.2005.11.062
    [86] Kolb EM, Rezende EL, Holness L, et al. (2013) Mice selectively bred for high voluntary wheel running have larger midbrains: support for the mosaic model of brain evolution. J Exp Biol 216: 515-523. doi: 10.1242/jeb.076000
    [87] Carro E, Nunez A, Busiguina S, et al. (2000) Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci 20: 2926-2933.
    [88] Ding Q, Vaynman S, Akhavan M, et al. (2006) Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function. Neuroscience 140: 823-833. doi: 10.1016/j.neuroscience.2006.02.084
    [89] McCusker RH, McCrea K, Zunich S, et al. (2006) Insulin-like growth factor-I enhances the biological activity of brain-derived neurotrophic factor on cerebrocortical neurons. J Neuroimmunol 179: 186-190. doi: 10.1016/j.jneuroim.2006.06.014
    [90] Carro E, Torres-Aleman I (2004) The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur J Pharmacol 490: 127-133. doi: 10.1016/j.ejphar.2004.02.050
    [91] Erickson KI, Raji CA, Lopez OL, et al. (2010) Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology 75: 1415-1422. doi: 10.1212/WNL.0b013e3181f88359
    [92] Bugg JM, Head D (2011) Exercise moderates age-related atrophy of the medial temporal lobe. Neurobiol Aging 32: 506-514. doi: 10.1016/j.neurobiolaging.2009.03.008
    [93] Boyle CP, Raji CA, Erickson KI, et al. (2015) Physical activity, body mass index, and brain atrophy in Alzheimer's disease. Neurobiol Aging 36 Suppl 1: S194-202.
    [94] Rovio S, Spulber G, Nieminen LJ, et al. (2010) The effect of midlife physical activity on structural brain changes in the elderly. Neurobiol Aging 31: 1927-1936. doi: 10.1016/j.neurobiolaging.2008.10.007
    [95] Erickson KI, Voss MW, Prakash RS, et al. (2011) Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A 108: 3017-3022. doi: 10.1073/pnas.1015950108
    [96] Burns JM, Cronk BB, Anderson HS, et al. (2008) Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology 71: 210-216. doi: 10.1212/01.wnl.0000317094.86209.cb
    [97] Honea RA, Thomas GP, Harsha A, et al. (2009) Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease. Alzheimer Dis Assoc Disord 23: 188-197. doi: 10.1097/WAD.0b013e31819cb8a2
    [98] van Praag H, Shubert T, Zhao C, et al. (2005) Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci 25: 8680-8685. doi: 10.1523/JNEUROSCI.1731-05.2005
    [99] Albeck DS, Sano K, Prewitt GE, et al. (2006) Mild forced treadmill exercise enhances spatial learning in the aged rat. Behav Brain Res 168: 345-348. doi: 10.1016/j.bbr.2005.11.008
    [100] Kramer AF, Erickson KI (2007) Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function. Trends Cogn Sci 11: 342-348. doi: 10.1016/j.tics.2007.06.009
    [101] Heyn P, Abreu BC, Ottenbacher KJ (2004) The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil 85: 1694-1704. doi: 10.1016/j.apmr.2004.03.019
    [102] Colcombe S, Kramer AF (2003) Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 14: 125-130. doi: 10.1111/1467-9280.t01-1-01430
    [103] Stones MJ, Kozma A (1989) Age, exercise, and coding performance. Psychol Aging 4: 190-194. doi: 10.1037/0882-7974.4.2.190
    [104] Kamijo K, Takeda Y, Hillman CH (2011) The relation of physical activity to functional connectivity between brain regions. Clin Neurophysiol 122: 81-89. doi: 10.1016/j.clinph.2010.06.007
    [105] Burdette JH, Laurienti PJ, Espeland MA, et al. (2010) Using network science to evaluate exercise-associated brain changes in older adults. Front Aging Neurosci 2: 23.
    [106] Voss MW, Prakash RS, Erickson KI, et al. (2010) Plasticity of brain networks in a randomized intervention trial of exercise training in older adults. Front Aging Neurosci 2.
    [107] Strawbridge WJ, Deleger S, Roberts RE, et al. (2002) Physical activity reduces the risk of subsequent depression for older adults. Am J Epidemiol 156: 328-334. doi: 10.1093/aje/kwf047
    [108] Lampinen P, Heikkinen E (2003) Reduced mobility and physical activity as predictors of depressive symptoms among community-dwelling older adults: an eight-year follow-up study. Aging Clin Exp Res 15: 205-211. doi: 10.1007/BF03324501
    [109] Lee Y, Park K (2008) Does physical activity moderate the association between depressive symptoms and disability in older adults? Int J Geriatr Psychiatry 23: 249-256. doi: 10.1002/gps.1870
    [110] Yoshiuchi K, Nakahara R, Kumano H, et al. (2006) Yearlong physical activity and depressive symptoms in older Japanese adults: cross-sectional data from the Nakanojo study. Am J Geriatr Psychiatry 14: 621-624. doi: 10.1097/01.JGP.0000200602.70504.9c
    [111] Salguero A, Martinez-Garcia R, Molinero O, et al. (2011) Physical activity, quality of life and symptoms of depression in community-dwelling and institutionalized older adults. Arch Gerontol Geriatr 53: 152-157. doi: 10.1016/j.archger.2010.10.005
    [112] Lee H, Lee JA, Brar JS, et al. (2014) Physical activity and depressive symptoms in older adults. Geriatr Nurs 35: 37-41. doi: 10.1016/j.gerinurse.2013.09.005
    [113] Maki Y, Ura C, Yamaguchi T, et al. (2012) Effects of intervention using a community-based walking program for prevention of mental decline: a randomized controlled trial. J Am Geriatr Soc 60: 505-510. doi: 10.1111/j.1532-5415.2011.03838.x
    [114] Penninx BW, Rejeski WJ, Pandya J, et al. (2002) Exercise and depressive symptoms: a comparison of aerobic and resistance exercise effects on emotional and physical function in older persons with high and low depressive symptomatology. J Gerontol B Psychol Sci Soc Sci 57: P124-132. doi: 10.1093/geronb/57.2.P124
    [115] Teixeira CM, Vasconcelos-Raposo J, Fernandes HM, et al. (2013) Physical Activity, Depression and Anxiety Among the Elderly. Social Indicators Research 113: 307-318. doi: 10.1007/s11205-012-0094-9
    [116] Lazarov O, Robinson J, Tang YP, et al. (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120: 701-713. doi: 10.1016/j.cell.2005.01.015
    [117] Adlard PA, Perreau VM, Pop V, et al. (2005) Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 25: 4217-4221. doi: 10.1523/JNEUROSCI.0496-05.2005
    [118] Kemppainen NM, Aalto S, Wilson IA, et al. (2006) Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology 67: 1575-1580. doi: 10.1212/01.wnl.0000240117.55680.0a
    [119] Klunk WE, Engler H, Nordberg A, et al. (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55: 306-319. doi: 10.1002/ana.20009
    [120] Klunk WE, Lopresti BJ, Ikonomovic MD, et al. (2005) Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 25: 10598-10606. doi: 10.1523/JNEUROSCI.2990-05.2005
    [121] Liang KY, Mintun MA, Fagan AM, et al. (2010) Exercise and Alzheimer's disease biomarkers in cognitively normal older adults. Ann Neurol 68: 311-318. doi: 10.1002/ana.22096
    [122] Vemuri P, Lesnick TG, Przybelski SA, et al. (2012) Effect of lifestyle activities on Alzheimer disease biomarkers and cognition. Ann Neurol 72: 730-738. doi: 10.1002/ana.23665
    [123] Brown BM, Peiffer JJ, Taddei K, et al. (2013) Physical activity and amyloid-beta plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Mol Psychiatry 18: 875-881. doi: 10.1038/mp.2012.107
    [124] Okonkwo OC, Schultz SA, Oh JM, et al. (2014) Physical activity attenuates age-related biomarker alterations in preclinical AD. Neurology 83: 1753-1760. doi: 10.1212/WNL.0000000000000964
    [125] Bennet AM, Di Angelantonio E, Ye Z, et al. (2007) Association of apolipoprotein E genotypes with lipid levels and coronary risk. Jama 298: 1300-1311. doi: 10.1001/jama.298.11.1300
    [126] Mahley RW, Nathan BP, Pitas RE (1996) Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease. Ann N Y Acad Sci 777: 139-145.
    [127] Weisgraber KH (1994) Apolipoprotein E: structure-function relationships. Adv Protein Chem 45: 249-302. doi: 10.1016/S0065-3233(08)60642-7
    [128] Weisgraber KH, Mahley RW (1996) Human apolipoprotein E: the Alzheimer's disease connection. Faseb J 10: 1485-1494.
    [129] Yaffe K, Haan M, Byers A, et al. (2000) Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54: 1949-1954. doi: 10.1212/WNL.54.10.1949
    [130] Szekely CA, Breitner JC, Fitzpatrick AL, et al. (2008) NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology 70: 17-24. doi: 10.1212/01.wnl.0000284596.95156.48
    [131] Qiu C, Winblad B, Fastbom J, et al. (2003) Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD. Neurology 61: 655-660. doi: 10.1212/WNL.61.5.655
    [132] Rovio S, Kareholt I, Helkala EL, et al. (2005) Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 4: 705-711. doi: 10.1016/S1474-4422(05)70198-8
    [133] Deeny SP, Poeppel D, Zimmerman JB, et al. (2008) Exercise, APOE, and working memory: MEG and behavioral evidence for benefit of exercise in epsilon4 carriers. Biol Psychol 78: 179-187. doi: 10.1016/j.biopsycho.2008.02.007
    [134] Etnier JL, Caselli RJ, Reiman EM, et al. (2007) Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitness. Med Sci Sports Exerc 39: 199-207. doi: 10.1249/01.mss.0000239399.85955.5e
    [135] Kivipelto M, Rovio S, Ngandu T, et al. (2008) Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med 12: 2762-2771. doi: 10.1111/j.1582-4934.2008.00296.x
    [136] Niti M, Yap KB, Kua EH, et al. (2008) Physical, social and productive leisure activities, cognitive decline and interaction with APOE-epsilon 4 genotype in Chinese older adults. Int Psychogeriatr 20: 237-251.
    [137] Schuit AJ, Feskens EJ, Launer LJ, et al. (2001) Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc 33: 772-777.
    [138] Yang SY, Weng PH, Chen JH, et al. (2014) Leisure activities, apolipoprotein E e4 status, and the risk of dementia. J Formos Med Assoc.
    [139] Luck T, Riedel-Heller SG, Luppa M, et al. (2014) Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer's disease dementia. Psychol Med 44: 1319-1329. doi: 10.1017/S0033291713001918
    [140] Podewils LJ, Guallar E, Kuller LH, et al. (2005) Physical Activity, APOE Genotype, and Dementia Risk: Findings from the Cardiovascular Health Cognition Study. Am J Epidemiol 161: 639-651. doi: 10.1093/aje/kwi092
    [141] Lindsay J, Laurin D, Verreault R, et al. (2002) Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156: 445-453. doi: 10.1093/aje/kwf074
    [142] Sabia S, Kivimaki M, Kumari M, et al. (2010) Effect of Apolipoprotein E epsilon4 on the association between health behaviors and cognitive function in late midlife. Mol Neurodegener 5: 23. doi: 10.1186/1750-1326-5-23
    [143] Taaffe DR, Irie F, Masaki KH, et al. (2008) Physical activity, physical function, and incident dementia in elderly men: the Honolulu-Asia Aging Study. J Gerontol A Biol Sci Med Sci 63: 529-535. doi: 10.1093/gerona/63.5.529
    [144] Smith JC, Nielson KA, Woodard JL, et al. (2014) Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer's disease. Front Aging Neurosci 6: 61.
    [145] Head D, Bugg JM, Goate AM, et al. (2012) Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition. Arch Neurol 69: 636-643. doi: 10.1001/archneurol.2011.845
    [146] Nichol K, Deeny SP, Seif J, et al. (2009) Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimers Dement 5: 287-294. doi: 10.1016/j.jalz.2009.02.006
    [147] Buttini M, Yu GQ, Shockley K, et al. (2002) Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. J Neurosci 22: 10539-10548.
    [148] Allen SJ, MacGowan SH, Tyler S, et al. (1997) Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. Neurosci Lett 239: 33-36. doi: 10.1016/S0304-3940(97)00872-0
    [149] Scarmeas N, Habeck C, Anderson KE, et al. (2004) Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele). Am J Geriatr Psychiatry 12: 596-605.
    [150] Rimajova M, Lenzo NP, Wu J-S, et al. (2007) Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEε4 carriers in the Australian population. Journal of Alzheimer's disease 13: 137-146.
    [151] Mosconi L, De Santi S, Brys M, et al. (2008) Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry 63: 609-618. doi: 10.1016/j.biopsych.2007.05.030
    [152] Hone E, Martins IJ, Fonte J, et al. (2003) Apolipoprotein E influences amyloid-beta clearance from the murine periphery. J Alzheimers Dis 5: 1-8.
    [153] Hone E, Martins IJ, Jeoung M, et al. (2005) Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding. J Alzheimers Dis 7: 303-314.
    [154] Mazur-Kolecka B, Frackowiak J, Kowal D, et al. (2002) Oxidative protein damage in cells engaged in beta-amyloidosis is related to apoE genotype. Neuroreport 13: 465-468. doi: 10.1097/00001756-200203250-00021
    [155] Overmyer M, Helisalmi S, Soininen H, et al. (1999) Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue. Dement Geriatr Cogn Disord 10: 252-257. doi: 10.1159/000017128
    [156] Taddei K, Clarnette R, Gandy SE, et al. (1997) Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. Neurosci Lett 223: 29-32. doi: 10.1016/S0304-3940(97)13394-8
    [157] Laws SM, Hone E, Gandy S, et al. (2003) Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 84: 1215-1236. doi: 10.1046/j.1471-4159.2003.01615.x
    [158] Laws SM, Hone E, Taddei K, et al. (2002) Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E. Mol Psychiatry 7: 886-890. doi: 10.1038/sj.mp.4001097
    [159] Casadei VM, Ferri C, Veglia F, et al. (1999) APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease. Neurology 53: 1888-1889.
    [160] Bueller JA, Aftab M, Sen S, et al. (2006) BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59: 812-815. doi: 10.1016/j.biopsych.2005.09.022
    [161] Lim YY, Villemagne VL, Laws SM, et al. (2014) Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study. PLoS One 9: e86498. doi: 10.1371/journal.pone.0086498
    [162] Feher A, Juhasz A, Rimanoczy A, et al. (2009) Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease. Alzheimer Dis Assoc Disord 23: 224-228. doi: 10.1097/WAD.0b013e318199dd7d
    [163] Brown BM, Bourgeat P, Peiffer JJ, et al. (2014) Influence of BDNF Val66Met on the relationship between physical activity and brain volume. Neurology 83: 1345-1352. doi: 10.1212/WNL.0000000000000867
    [164] Teng HK, Teng KK, Lee R, et al. (2005) ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 25: 5455-5463. doi: 10.1523/JNEUROSCI.5123-04.2005
    [165] Zhang Y, Wang B, Wan H, et al. (2013) Meta-analysis of the insulin degrading enzyme polymorphisms and susceptibility to Alzheimer's disease. Neurosci Lett 541: 132-137. doi: 10.1016/j.neulet.2013.01.051
    [166] Vargas T, Martinez-Garcia A, Antequera D, et al. (2011) IGF-I gene variability is associated with an increased risk for AD. Neurobiol Aging 32: 556 e553-511.
    [167] Braskie MN, Boyle CP, Rajagopalan P, et al. (2014) Physical activity, inflammation, and volume of the aging brain. Neuroscience 273: 199-209. doi: 10.1016/j.neuroscience.2014.05.005
    [168] Licastro F, Porcellini E, Caruso C, et al. (2006) Genetic risk profiles for Alzheimer's disease: Integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging.
    [169] Culpan D, MacGowan SH, Ford JM, et al. (2003) Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease. Neurosci Lett 350: 61-65. doi: 10.1016/S0304-3940(03)00854-1
    [170] Du Y, Dodel RC, Eastwood BJ, et al. (2000) Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology 55: 480-483. doi: 10.1212/WNL.55.4.480
    [171] Grimaldi LM, Casadei VM, Ferri C, et al. (2000) Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol 47: 361-365. doi: 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N
    [172] Hedley R, Hallmayer J, Groth DM, et al. (2002) Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Ann Neurol 51: 795-797. doi: 10.1002/ana.10196
    [173] Koivisto AM, Helisalmi S, Pihlajamaki J, et al. (2005) Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population. J Neurogenet 19: 155-161. doi: 10.1080/01677060600569721
    [174] Laws SM, Perneczky R, Wagenpfeil S, et al. (2005) TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels. Hum Mutat 26: 29-35. doi: 10.1002/humu.20180
    [175] Lio D, Annoni G, Licastro F, et al. (2006) Tumor necrosis factor-alpha -308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev 127: 567-571. doi: 10.1016/j.mad.2006.01.015
    [176] Nicoll JA, Mrak RE, Graham DI, et al. (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 47: 365-368. doi: 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G
    [177] Sciacca FL, Ferri C, Licastro F, et al. (2003) Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease. Neurobiol Aging 24: 927-931. doi: 10.1016/S0197-4580(03)00011-3
    [178] Shibata N, Ohnuma T, Takahashi T, et al. (2002) Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 114: 436-439. doi: 10.1002/ajmg.10417
    [179] Ferencz B, Laukka EJ, Welmer AK, et al. (2014) The benefits of staying active in old age: physical activity counteracts the negative influence of PICALM, BIN1, and CLU risk alleles on episodic memory functioning. Psychol Aging 29: 440-449. doi: 10.1037/a0035465
    [180] Holler CJ, Davis PR, Beckett TL, et al. (2014) Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology. J Alzheimers Dis 42: 1221-1227.
    [181] Xu W, Tan L, Yu JT (2014) The Role of PICALM in Alzheimer's Disease. Mol Neurobiol.
    [182] Herring A, Donath A, Yarmolenko M, et al. (2012) Exercise during pregnancy mitigates Alzheimer-like pathology in mouse offspring. Faseb J 26: 117-128. doi: 10.1096/fj.11-193193
    [183] Parnpiansil P, Jutapakdeegul N, Chentanez T, et al. (2003) Exercise during pregnancy increases hippocampal brain-derived neurotrophic factor mRNA expression and spatial learning in neonatal rat pup. Neurosci Lett 352: 45-48. doi: 10.1016/j.neulet.2003.08.023
    [184] Horsburgh S, Robson-Ansley P, Adams R, et al. (2015) Exercise and inflammation-related epigenetic modifications: focus on DNA methylation. Exerc Immunol Rev 21: 26-41.
    [185] Kaliman P, Parrizas M, Lalanza JF, et al. (2011) Neurophysiological and epigenetic effects of physical exercise on the aging process. Ageing Res Rev 10: 475-486. doi: 10.1016/j.arr.2011.05.002
    [186] Ntanasis-Stathopoulos J, Tzanninis JG, Philippou A, et al. (2013) Epigenetic regulation on gene expression induced by physical exercise. J Musculoskelet Neuronal Interact 13: 133-146.
    [187] Hess NCL, Dieberg G, McFarlane JR, et al. (2014) The effect of exercise intervention on cognitive performance in persons at risk of, or with, dementia: A systematic review and meta-analysis. Healthy Aging Research 3: 1-10.
    [188] Holthoff VA, Marschner K, Scharf M, et al. (2015) Effects of physical activity training in patients with Alzheimer's dementia: results of a pilot RCT study. PLoS One 10: e0121478. doi: 10.1371/journal.pone.0121478
    [189] Etnier JL, Labban JD, Karper WB, et al. (2015) Innovative Research Design Exploring the Effects of Physical Activity and Genetics on Cognitive Performance in Community-Based Older Adults. J Aging Phys Act.
    [190] Lautenschlager NT, Cox KL, Flicker L, et al. (2008) Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 300: 1027-1037. doi: 10.1001/jama.300.9.1027
    [191] Buchman AS, Boyle PA, Yu L, et al. (2012) Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 78: 1323-1329. doi: 10.1212/WNL.0b013e3182535d35
    [192] Zlatar ZZ, McGregor KM, Towler S, et al. (2015) Self-reported physical activity and objective aerobic fitness: differential associations with gray matter density in healthy aging. Front Aging Neurosci 7: 5.
    [193] Akbaraly TN, Portet F, Fustinoni S, et al. (2009) Leisure activities and the risk of dementia in the elderly: results from the Three-City Study. Neurology 73: 854-861. doi: 10.1212/WNL.0b013e3181b7849b
    [194] Scarmeas N, Levy G, Tang MX, et al. (2001) Influence of leisure activity on the incidence of Alzheimer's disease. Neurology 57: 2236-2242. doi: 10.1212/WNL.57.12.2236
    [195] Schooler C, Mulatu MS (2001) The reciprocal effects of leisure time activities and intellectual functioning in older people: a longitudinal analysis. Psychol Aging 16: 466-482. doi: 10.1037/0882-7974.16.3.466
    [196] Verghese J, Lipton RB, Katz MJ, et al. (2003) Leisure activities and the risk of dementia in the elderly. N Engl J Med 348: 2508-2516. doi: 10.1056/NEJMoa022252
    [197] Barnes LL, Mendes de Leon CF, Wilson RS, et al. (2004) Social resources and cognitive decline in a population of older African Americans and whites. Neurology 63: 2322-2326. doi: 10.1212/01.WNL.0000147473.04043.B3
    [198] Bennett DA, Schneider JA, Tang Y, et al. (2006) The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol 5: 406-412. doi: 10.1016/S1474-4422(06)70417-3
    [199] Trost SG, Owen N, Bauman AE, et al. (2002) Correlates of adults' participation in physical activity: review and update. Med Sci Sports Exerc 34: 1996-2001. doi: 10.1097/00005768-200212000-00020
    [200] Dergance JM, Calmbach WL, Dhanda R, et al. (2003) Barriers to and benefits of leisure time physical activity in the elderly: differences across cultures. J Am Geriatr Soc 51: 863-868. doi: 10.1046/j.1365-2389.2003.51271.x
    [201] Kempermann G, Gast D, Gage FH (2002) Neuroplasticity in old age: sustained fivefold induction of hippocampal neurogenesis by long-term environmental enrichment. Ann Neurol 52: 135-143. doi: 10.1002/ana.10262
    [202] Hannan AJ (2014) Environmental enrichment and brain repair: harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticity. Neuropathol Appl Neurobiol 40: 13-25. doi: 10.1111/nan.12102
    [203] Ball K, Berch DB, Helmers KF, et al. (2002) Effects of cognitive training interventions with older adults: a randomized controlled trial. Jama 288: 2271-2281. doi: 10.1001/jama.288.18.2271
    [204] Calero MD, Navarro E (2007) Cognitive plasticity as a modulating variable on the effects of memory training in elderly persons. Arch Clin Neuropsychol 22: 63-72.
    [205] Engvig A, Fjell AM, Westlye LT, et al. (2010) Effects of memory training on cortical thickness in the elderly. Neuroimage 52: 1667-1676. doi: 10.1016/j.neuroimage.2010.05.041
    [206] Rozzini L, Costardi D, Chilovi BV, et al. (2007) Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. Int J Geriatr Psychiatry 22: 356-360. doi: 10.1002/gps.1681
    [207] Zanetti O, Binetti G, Magni E, et al. (1997) Procedural memory stimulation in Alzheimer's disease: impact of a training programme. Acta Neurol Scand 95: 152-157. doi: 10.1111/j.1600-0404.1997.tb00087.x
    [208] Zanetti O, Zanieri G, Di Giovanni G, et al. (2001) Effectiveness of procedural memory stimulation in mild Alzheimer's disease patients: A controlled study. Neuropsychol Rehabil 11: 263-272. doi: 10.1080/09602010042000088
    [209] Wilson RS, Mendes De Leon CF, Barnes LL, et al. (2002) Participation in cognitively stimulating activities and risk of incident Alzheimer disease. Jama 287: 742-748. doi: 10.1001/jama.287.6.742
    [210] Wilson RS, Scherr PA, Schneider JA, et al. (2007) Relation of cognitive activity to risk of developing Alzheimer disease. Neurology 69: 1911-1920. doi: 10.1212/01.wnl.0000271087.67782.cb
    [211] Shah T, Verdile G, Sohrabi H, et al. (2014) A combination of physical activity and computerized brain training improves verbal memory and increases cerebral glucose metabolism in the elderly. Transl Psychiatry 4: e487. doi: 10.1038/tp.2014.122
    [212] Gates NJ, Sachdev P (2014) Is cognitive training an effective treatment for preclinical and early Alzheimer's disease? J Alzheimers Dis 42 Suppl 4: S551-559.
    [213] Ngandu T, Lehtisalo J, Solomon A, et al. (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385: 2255-2263. doi: 10.1016/S0140-6736(15)60461-5
    [214] Ellis KA, Bush AI, Darby D, et al. (2009) The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. Int Psychogeriatr 21: 672-687. doi: 10.1017/S1041610209009405
    [215] Mueller SG, Weiner MW, Thal LJ, et al. (2005) Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 1: 55-66. doi: 10.1016/j.jalz.2005.06.003
    [216] Bateman RJ, Xiong C, Benzinger TL, et al. (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367: 795-804. doi: 10.1056/NEJMoa1202753
    [217] Raber J, Wong D, Buttini M, et al. (1998) Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci U S A 95: 10914-10919. doi: 10.1073/pnas.95.18.10914
    [218] Ungar L, Altmann A, Greicius MD (2014) Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction. Brain Imaging Behav 8: 262-273. doi: 10.1007/s11682-013-9272-x
  • This article has been cited by:

    1. Zia Ud Din Taj, Ahmad Bilal, Muhammad Awais, Shuaib Salamat, Messam Abbas, Adnan Maqsood, Design exploration and optimization of aerodynamics and radar cross section for a fighter aircraft, 2023, 133, 12709638, 108114, 10.1016/j.ast.2023.108114
    2. Tiansheng Miao, Jiayuan Guo, Guanghua Li, He Huang, Inversion-based identification of DNAPLs-contaminated groundwater based on surrogate model of deep convolutional neural network, 2023, 23, 1606-9749, 129, 10.2166/ws.2022.437
    3. Abdelwahid Boutemedjet, Smail Khalfallah, Mahfoudh Cerdoun, Abdelkader Benaouali, A multi-objective optimization strategy based on combined meta-models: Application to a wind turbine, 2024, 0954-4089, 10.1177/09544089231223859
    4. Roger Ballester Claret, Ludovic Coelho, Christian Fagiano, Cédric Julien, Didier Lucor, Nicolò Fabbiane, Reliability based optimisation of composite plates under aeroelastic constraints via adapted surrogate modelling and genetic algorithms, 2024, 347, 02638223, 118461, 10.1016/j.compstruct.2024.118461
    5. Chongjian Yang, Junle Yang, Yixiao Qin, Research on Comparative of Multi-Surrogate Models to Optimize Complex Truss Structures, 2024, 28, 1226-7988, 2268, 10.1007/s12205-024-0196-3
    6. Zhenglei He, Mengna Hong, Hongze Zheng, Jinfeng Wang, Qingang Xiong, Yi Man, Towards low-carbon papermaking wastewater treatment process based on Kriging surrogate predictive model, 2023, 425, 09596526, 139039, 10.1016/j.jclepro.2023.139039
    7. R. Allahvirdizadeh, A. Andersson, R. Karoumi, Improved dynamic design method of ballasted high-speed railway bridges using surrogate-assisted reliability-based design optimization of dependent variables, 2023, 238, 09518320, 109406, 10.1016/j.ress.2023.109406
    8. Yupeng Cui, Yang Yu, Siyuan Cheng, Mingxiu Wei, Yu Pan, Zewei Dong, Multi-performance reliability-based concept-detailed co-design of offshore structures using modified conjugate FR algorithm, 2024, 300, 00298018, 117275, 10.1016/j.oceaneng.2024.117275
    9. Debiao Meng, Hengfei Yang, Shiyuan Yang, Yuting Zhang, Abílio M.P. De Jesus, José Correia, Tiago Fazeres-Ferradosa, Wojciech Macek, Ricardo Branco, Shun-Peng Zhu, Kriging-assisted hybrid reliability design and optimization of offshore wind turbine support structure based on a portfolio allocation strategy, 2024, 295, 00298018, 116842, 10.1016/j.oceaneng.2024.116842
    10. Debiao Meng, Yipeng Guo, Yihe Xu, Shiyuan Yang, Yongqiang Guo, Lidong Pan, Xinkai Guo, Saddlepoint Approximation Method in Reliability Analysis: A Review, 2024, 139, 1526-1506, 2329, 10.32604/cmes.2024.047507
  • Reader Comments
  • © 2015 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(7004) PDF downloads(1101) Cited by(2)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog